VERIFIED QUALITY · FULLY DOCUMENTED · GLOBAL SUPPLY
Guangzhou Yantai Biotechnology Co., Ltd.
BPC157,TB500 5mg+5mg(Blend)*10vials — image 1 of 1

BPC157,TB500 5mg+5mg(Blend)*10vials

SKU: CBR018

$138.00

In stock

BPC 157 is a synthetic 15-amino-acid peptide, also known as Body Protection Compound 157.BPC 157 promotes tissue repair, offers neuroprotection, and has anti-ulcer, anti-inflammatory and antioxidant properties. TB500, a synthetic derivative of the polypeptide molecule thymosin beta - 4 (Tβ4), enhances cell migration, proliferation and differentiation, thereby boosting tissue repair and regeneration. When combined, BPC 157 and TB500 display significant synergy in tissue repair, anti-inflammation…

Request a quote

Online ordering is unavailable on this site. Send an enquiry and we will reply with pricing and lead times.

Documentation: Search the COA portal

Shipping: Calculated at checkout

Description

BPC 157


BPC 157 is a synthetic peptide composed of fifteen amino acids, and its full name is Body Protection Compound 157. Research has shown that BPC 157 possesses multiple biological functions, including accelerating tissue repair, neuroprotection, anti-ulcer, anti-inflammatory, and antioxidant effects. In the field of tissue repair, BPC 157 can significantly promote the regeneration of connective tissues such as the skin, tendons, and ligaments, and it has demonstrated remarkable efficacy especially in the healing of burn wounds. Its mechanism of action involves enhancing the proliferation, migration, and lumen formation capabilities of endothelial cells, thereby promoting angiogenesis and tissue regeneration.


In terms of neuroprotection, BPC 157 has a positive impact on the central nervous system by regulating the levels of neurotransmitters such as serotonin and dopamine, and it can improve problems such as indigestion, absorption disorders, and immunodeficiency. In addition, BPC 157 exhibits significant anti-ulcer and anti-inflammatory properties, which can maintain the integrity of the gastrointestinal mucosa and prevent pathogens and toxins from invading the intestine. In terms of liver protection, this molecule significantly protects liver function by inhibiting abnormal cell proliferation, maintaining the structural integrity of hepatocytes, stabilizing enzymatic indices, reducing the levels of inflammatory factors, and inhibiting liver fibrosis.


Compared with other drugs, the advantage of BPC 157 lies in its low toxicity and the absence of significant side effects, showing good safety and tolerance in various animal models. Currently, BPC 157 not only has unique curative effects in the treatment of gastrointestinal diseases but also shows potential application values in promoting tissue regeneration, improving the functions of the central nervous system, and the field of anti-aging.


TB500


TB500, a synthetic derivative of Thymosin Beta-4 (Tβ4), is a polypeptide molecule. Its core mechanism achieves dynamic regulation by precisely controlling the balance between the assembly and disassembly of actin within the cytoskeleton. This molecule can significantly enhance the abilities of cell migration, proliferation, and differentiation, thus playing a key regulatory role in the process of tissue repair and regeneration. In the field of skin wound repair, TB500 can accelerate the wound closure process, promote the orderly deposition of collagen, and inhibit the abnormal proliferation of pathological scar tissues; for metabolic diseases, it can effectively alleviate the pathological processes mediated by inflammation, such as non-alcoholic fatty liver disease and pulmonary fibrosis, by inhibiting the release of pro-inflammatory cytokines; in terms of cardiovascular protection, during the acute phase of myocardial infarction, TB500 can protect the surviving cardiomyocytes, activate the endogenous angiogenesis program, optimize the myocardial microcirculation network, and ultimately enhance the cardiac pumping efficiency.


It is worth noting that TB500 exhibits high bioavailability, a multi-target synergistic effect, and excellent biocompatibility. Its unique tissue-targeting property enables it to precisely act on the microenvironment of damaged tissues, significantly reducing the risk of systemic exposure while achieving targeted therapy. This molecular mechanism based on the regulation of actin dynamics not only provides an innovative treatment strategy for tissue regeneration medicine but also lays a solid theoretical foundation and empirical support for clinical translational applications. By simultaneously activating multiple pathways of angiogenesis, anti-inflammation, and cytoprotection, TB500 shows broad application prospects in maintaining tissue homeostasis and functional repair.


Summary


The combined use of BPC 157 and TB500 exhibits significant synergistic effects in multiple fields such as tissue repair, anti-inflammation, and angiogenesis. This synergistic effect not only enhances the therapeutic effects of a single molecule but also expands its application scope, providing new possibilities for the treatment of various diseases.


Tissue Repair and Regeneration

BPC 157 accelerates tissue repair by promoting collagen synthesis, the proliferation and migration of fibroblasts, and enhancing angiogenesis. TB500 promotes cell migration and differentiation by regulating the dynamic balance of actin, providing structural support for tissue repair. When used in combination, BPC 157 and TB500 act synergistically at the cellular level, significantly enhancing the ability of tissue regeneration. For example, in skin wound repair, BPC 157 accelerates wound closure, while TB500 promotes the orderly deposition of collagen, jointly inhibiting the abnormal hyperplasia of pathological scar tissues. In tendon and ligament injuries, BPC 157 promotes angiogenesis, providing nutritional support for repair, while TB500 promotes cell migration to the injury site by regulating the cytoskeleton, accelerating tissue regeneration.


Anti-inflammation and Immune Regulation

BPC 157 has significant anti-inflammatory properties, which can reduce the release of pro-inflammatory factors such as TNF-α and IL-6, and at the same time enhance the expression of anti-inflammatory factors such as IL-10. TB500 further alleviates inflammation by inhibiting the immune response related to inflammation. When used in combination, BPC 157 and TB500 form a synergistic effect in inhibiting the inflammatory response, which can not only quickly relieve acute inflammation but also effectively control the development of chronic inflammation. This synergistic effect is particularly significant in inflammation-related diseases such as non-alcoholic fatty liver disease and pulmonary fibrosis, which can significantly improve the pathological process and promote the recovery of tissue function.


Angiogenesis and Nutrient Delivery

Both BPC 157 and TB500 can promote angiogenesis and improve the blood supply to damaged tissues. BPC 157 promotes angiogenesis by enhancing the proliferation, migration, and lumen formation capabilities of endothelial cells, providing the necessary nutrients and oxygen for tissue repair. TB500 promotes the migration and differentiation of vascular endothelial cells by regulating actin dynamics, further optimizing the formation of the vascular network. When used in combination, BPC 157 and TB500 form a complementary mechanism in the process of angiogenesis. BPC 157 provides basic support for angiogenesis, while TB500 optimizes the structure and function of blood vessels, thus significantly improving the efficiency and quality of tissue repair.


Exercise Recovery and Anti-fatigue

In terms of exercise recovery, the combined use of BPC 157 and TB500 can significantly shorten the recovery time of exercise-induced injuries. BPC 157 reduces muscle soreness and inflammation through promoting tissue repair and anti-inflammatory effects, while TB500 enhances the repair and regeneration ability of muscle cells by regulating the cytoskeleton. When used in combination, BPC 157 and TB500 form a synergistic effect in muscle injury repair, which can not only quickly relieve muscle soreness but also significantly improve muscle strength and endurance, accelerating the recovery of athletic performance.


Anti-aging

The combined use of BPC 157 and TB500 shows potential anti-aging and longevity properties by promoting cell repair and regeneration and supporting the health of the cardiovascular and nervous systems. BPC 157 protects cells from free radical damage through anti-inflammatory and antioxidant effects, while TB500 maintains the normal function and structure of cells by regulating the cytoskeleton. When used in combination, BPC 157 and TB500 form a synergistic protection mechanism at the cellular level, which can not only delay cell aging but also enhance the regenerative capacity of cells, thus improving the overall health status of the body and delaying the aging process.


Postoperative Recovery and Chronic Disease Management

In postoperative recovery and chronic disease management, the combined use of BPC 157 and TB500 can significantly accelerate tissue repair and improve the overall health status. BPC 157 reduces postoperative complications through promoting tissue repair and anti-inflammatory effects, while TB500 enhances the tissue regeneration ability by regulating the cytoskeleton. When used in combination, BPC 157 and TB500 form a synergistic effect in postoperative recovery, which can not only accelerate wound healing but also significantly improve the functional recovery after surgery and enhance the quality of life of patients.


About The Author

The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.


ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  


The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.

Research use only

All products listed on this website are supplied strictly for laboratory and scientific research purposes. They are not drugs, foods, cosmetics or medical devices, and are not intended for human or veterinary consumption, diagnosis, treatment or any in-vivo application. Purchasers are responsible for confirming that their intended use complies with all applicable laws and institutional policies.

Read the full disclaimer

Related products

Bam15,Slu-PP-332 25mg+100mcg(Blend)*10vials

Bam15,Slu-PP-332 25mg+100mcg(Blend)*10vials

This composite formulation is employed to investigate the synergistic effects of peptide signaling in metabolic and central nervous system regulation. Its function manifests in the integrated regulation of multiple signaling pathways, involving processes related to energy metabolism and central nervous system control. Its mechanism facilitates the study of interactions within complex regulatory networks through synergistic interactions between peptides with distinct functions. It holds experime…

$96.00
Tesamoreli,Ipamorelin,CJC1295 6/3/3(Blend)*10vials

Tesamoreli,Ipamorelin,CJC1295 6/3/3(Blend)*10vials

This triple combination is used to study the multi-level synergistic regulatory mechanisms of the growth hormone axis. Tesamoreli primarily acts on upstream regulatory signals, Ipamorelin stimulates growth hormone release through selective pathways, while CJC-1295 prolongs the duration of endogenous signaling. By covering distinct regulatory nodes, this triad enables systematic investigation of GH secretion rhythms, feedback control, and endocrine system synergism. This combination holds signif…

$160.00
Tesamoreli,Ipamorelin 10/3(Blend)*10vials

Tesamoreli,Ipamorelin 10/3(Blend)*10vials

Tesa Ipa Blend combines Tesamoreli with Ipamorelin to investigate the multi-pathway regulation of growth hormone release. Tesamoreli primarily acts on upstream regulatory signals, while Ipamorelin directly influences the release process at the pituitary level. This dual-stimulation pathway mechanism aids in studying the rhythmic characteristics and regulatory intensity of the growth hormone axis. This combination provides a critical model for exploring synergistic regulation in studies of metab…

$170.00
CJC1295,Ipamorelin 10/10 (Blend)*10vials

CJC1295,Ipamorelin 10/10 (Blend)*10vials

This combination is used for the synergistic regulation mechanism of the growth hormone axis. CJC-1295 prolongs the duration of endogenous growth hormone release signals, while Ipamorelin selectively stimulates growth hormone secretion. Mechanistically complementary, they act at distinct regulatory levels. Their combined use facilitates investigation of growth hormone secretion rhythms, feedback regulation, and endocrine system synergistic mechanisms. This combination holds significant experime…

$190.00